Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (17 Jun 2022), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | JP | 17 Jun 2022 |